Recipharm, Astimex to Collaborate on Development and Manufacturing

Recipharm and Astimex Pharma have today announced the formation of a collaboration agreement for the development and manufacture of a pharmaceutical product.

The formulation development work will take place at the Recipharm Pharmaceutical Development site located in Solna close to Stockholm. Astimex Pharma also has the opportunity to choose Recipharm as the future manufacturer for the product.

Additionally, Astimex is in discussions with Recipharm for engagement to carry out other manufacturing and development contractual projects.